Icosavax, Inc.
Icosavax, Inc.（ICVX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ICVX · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
19
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Icosavax, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
ICVX 季度内部人买卖趋势
ICVX 内幕交易卖出 · ICVX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
ICVX 高管卖出股份 · ICVX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Feb 19, 2024 | RA CAPITAL MANAGEMENT, L.P. Director | Other | 638,668 | $9.58M⚡ | Form 4 |
| Feb 19, 2024 | Simpson Adam K. other: See Remarks | Other | 129,032 | $1.94M⚡ | Form 4 |
| Feb 19, 2024 | Veneman Ann M other: See Remarks | Other | 11,209 | $168K | Form 4 |
| Feb 19, 2024 | Veneman Ann M other: See Remarks | Other | 2,834 | — | Form 4 |
| Feb 19, 2024 | Cearley Cassia other: See Remarks | Other | 131,799 | $1.98M⚡ | Form 4 |
| Feb 19, 2024 | FIELDS HEIDI other: See Remarks | Other | 11,376 | $171K | Form 4 |
| Feb 19, 2024 | FIELDS HEIDI other: See Remarks | Other | 2,917 | — | Form 4 |
| Feb 19, 2024 | Wassil Jim other: See Remarks | Other | 7,392 | — | Form 4 |
| Feb 19, 2024 | Wassil Jim other: See Remarks | Other | 3,695 | $55K | Form 4 |
| Feb 19, 2024 | Russo Thomas Joseph other: See Remarks | Other | 39,367 | $591K | Form 4 |
| Feb 19, 2024 | Shiver John W. other: See Remarks | Other | 8,066 | $121K | Form 4 |
| Feb 19, 2024 | Shiver John W. other: See Remarks | Other | 2,833 | — | Form 4 |
| Feb 19, 2024 | MCDADE MARK other: See Remarks | Other | 3,510,228 | $52.65M⚡ | Form 4 |
| Feb 19, 2024 | Kanesa-thasan Niranjan other: See Remarks | Other | 223,980 | $3.36M⚡ | Form 4 |
| Feb 1, 2024 | Simpson Adam K. CEO · Director | Gift | 6,532 | — | Form 4 |
| Feb 1, 2024 | Simpson Adam K. CEO · Director | Option | 15,000 | $16K | Form 4 |
| Feb 1, 2024 | Simpson Adam K. CEO · Director | Sale | 15,000 | $229K | Form 4 |
| Jan 22, 2024 | Simpson Adam K. CEO · Director | Option | 93,227 | $97K | Form 4 |
| Jan 22, 2024 | Simpson Adam K. CEO · Director | Option | 4,789 | $4K | Form 4 |
| Jan 4, 2023 | Kanesa-thasan Niranjan Chief Medical Officer | Option | 5,972 | $90K | Form 4 |
| Jan 4, 2023 | Kanesa-thasan Niranjan Chief Medical Officer | Option | 11,947 | $70K | Form 4 |
| Jan 4, 2023 | Kanesa-thasan Niranjan Chief Medical Officer | Option | 74,648 | $78K | Form 4 |
| Jan 4, 2023 | Kanesa-thasan Niranjan Chief Medical Officer | Option | 13,806 | $12K | Form 4 |
| Jan 4, 2023 | Kanesa-thasan Niranjan Chief Medical Officer | Sale | 106,373 | $1.67M⚡ | Form 4 |
| Jan 2, 2024 | Simpson Adam K. CEO · Director | Option | 15,000 | $16K | Form 4 |
Kanesa-thasan Niranjan
other: See Remarks
日期
Feb 19
股数
223,980
均价
$15.00
总金额
$3.36M ⚡
Kanesa-thasan Niranjan
Chief Medical Officer
日期
Jan 4
股数
5,972
均价
$15.00
总金额
$90K
Kanesa-thasan Niranjan
Chief Medical Officer
日期
Jan 4
股数
11,947
均价
$5.90
总金额
$70K
Kanesa-thasan Niranjan
Chief Medical Officer
日期
Jan 4
股数
74,648
均价
$1.04
总金额
$78K
Kanesa-thasan Niranjan
Chief Medical Officer
日期
Jan 4
股数
13,806
均价
$0.84
总金额
$12K
Kanesa-thasan Niranjan
Chief Medical Officer
日期
Jan 4
股数
106,373
均价
$15.70
总金额
$1.67M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ICVX 内幕交易
ICVX 内幕交易
Icosavax, Inc.（ICVX）内幕交易数据来源于公司内部人（包括ICVX）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。ICVX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Icosavax, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ICVX 内幕交易 · 5个问题Icosavax, Inc.（ICVX）的内部人包括高管和董事，如ICVX等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026